References

1. Hahn, S.; Holzgreve, W. Prenatal diagnosis using fetal cells and cell-free fetal DNA in maternal blood: What is currently feasible? Clin. Obstet. Gynecol. 2002, 45, 649656. Discussion 730-732.

2. Bianchi, D.W.; Lo, Y.M. Fetomaternal cellular and plasma DNA trafficking: The Yin and the Yang. Ann. N.Y. Acad. Sci. 2001, 945, 119-131.

3. Bianchi, D.W.; Simpson, J.L.; Jackson, L.G.; Elias, S. Holzgreve, W.; Evans, M.I.; Dukes, K.A.; Sullivan, L.M. Klinger, K.W.; Bischoff, F.Z.; Hahn, S.; Johnson, K.L. Lewis D.; Wapner, R.J.; de la Cruz, F. Fetal gender and aneuploidy detection using fetal cells in maternal blood: Analysis of NIFTY I data. National Institute of Child Health and Development Fetal Cell Isolation Study. Prenat. Diagn. 2002, 22, 609-615.

4. Zamerowski, S.T.; Lumley, M.A.; Arreola, R.A.; Dukes, K.; Sullivan, L. Favorable attitudes toward testing for chromosomal abnormalities via analysis of fetal cells in maternal blood. Genet. Med. 2001, 3, 301-309.

5. Oosterwijk, J.C.; Knepfle, C.F.; Mesker, W.E.; Vrolijk, H.; Sloos, W.C.; Pattenier, H.; Ravkin, I.; van Ommen, G.J.; Kanhai, H.H.; Tanke, H.J. Strategies for rare-event detection: An approach for automated fetal cell detection in maternal blood. Am. J. Hum. Genet. 1998, 63, 1783-1792.

6. Bianchi, D.W.; Williams, J.M.; Sullivan, L.M.; Hanson, F.W.; Klinger, K.W.; Shuber, A.P. PCR quantitation of fetal cells in maternal blood in normal and aneuploid pregnancies. Am. J. Hum. Genet. 1997, 61, 822-829.

7. Oudejans, C.B.; Tjoa, M.L.; Westerman, B.A.; Mulders, M.A.; Van Wijk, I.J.; Van Vugt, J.M. Circulating tropho-blast in maternal blood. Prenat. Diagn. 2003, 23, 111-116.

8. Lo, Y.M.; Corbetta, N.; Chamberlain, P.F.; Rai, V.; Sargent, I.L.; Redman, C.W.; Wainscoat, J.S. Presence of fetal DNA in maternal plasma and serum. Lancet 1997, 350, 485-487.

9. Chen, X.Q.; Stroun, M.; Magnenat, J.L.; Nicod, L.P.; Kurt, A.M.; Lyautey, J.; Lederrey, C.; Anker, P. Microsatellite alterations in plasma DNA of small cell lung cancer patients. Nat. Med. 1996, 2, 1033-1035.

10. Lo, Y.M. Fetal DNA in maternal plasma/serum: The first 5 years. Pediatr. Res. 2003, 53, 7-16.

11. Lo, Y.M.; Zhang, J.; Leung, T.N.; Lau, T.K.; Chang, A.M.; Hjelm, N.M. Rapid clearance of fetal DNA from maternal plasma. Am. J. Hum. Genet. 1999, 64, 218-224.

12. Lo, Y.M.; Lau, T.K.; Zhang, J.; Leung, T.N.; Chang, A.M.; Hjelm, N.M.; Elmes, R.S.; Bianchi, D.W. Increased fetal DNA concentrations in the plasma of pregnant women carrying fetuses with trisomy 21. Clin. Chem. 1999, 45, 1747-1751.

13. Zhong, X.Y.; Burk, M.R.; Troeger, C.; Jackson, L.R.; Holzgreve, W.; Hahn, S. Fetal DNA in maternal plasma is elevated in pregnancies with aneuploid fetuses. Prenat. Diagn. 2000, 20, 795-879.

14. Lo, Y.M.; Leung, T.N.; Tein, M.S.; Sargent, I.L.; Zhang, J.; Lau, T.K.; Haines, C.J.; Redman, C.W. Quantitative abnormalities of fetal DNA in maternal serum in preeclampsia. Clin. Chem. 1999, 45, 184-188.

15. Zhong, X.Y.; Laivuori, H.; Livingston, J.C.; Ylikorkala, O.; Sibai, B.M.; Holzgreve, W.; Hahn, S. Elevation of both maternal and fetal extracellular circulating deoxyribonu-cleic acid concentrations in the plasma of pregnant women with preeclampsia. Am. J. Obstet. Gynecol. 2001, 184, 414-419.

16. Swinkels, D.W.; de Kok, J.B.; Hendriks, J.C.; Wiegerinck, E.; Zusterzeel, P.L.; Steegers, E.A. Hemolysis, elevated liver enzymes, and low platelet count (HELLP) syndrome as a complication of preeclampsia in pregnant women increases the amount of cell-free fetal and maternal DNA in maternal plasma and serum. Clin. Chem. 2002, 48, 650-653.

17. Zhong, X.Y.; Hahn, S.; Holzgreve, W. Prenatal identification of fetal genetic traits. Lancet 2001, 357, 310311.

18. Ng, E.K.; Tsui, N.B.; Lau, T.K.; Leung, T.N.; Chiu, R.W.; Panesar, N.S.; Lit, L.C.; Chan, K.W.; Lo, Y.M. mRNA of placental origin is readily detectable in maternal plasma. Proc. Natl. Acad. Sci. U. S. A. 2003, 100, 4748-4753.

19. Ng, E.K.; Leung, T.N.; Tsui, N.B.; Lau, T.K.; Panesar, N.S.; Chiu, R.W. et al. The concentration of circulating corticotropin-releasing hormone mRNA in maternal plasma is increased in preeclampsia. Clin. Chem. 2003, 49, 727-731.

20. Leung, T.N.; Zhang, J.; Lau, T.K.; Chan, L.Y.; Lo, Y.M. Increased maternal plasma fetal DNA concentrations in women who eventually develop preeclampsia. Clin. Chem. 2001, 47, 137-139.

21. Zhong, X.Y.; Holzgreve, W.; Hahn, S. The levels of circulatory cell free fetal DNA in maternal plasma are elevated prior to the onset of preeclampsia. Hypertens. Pregnancy 2002, 21, 77-83.

22. Oudejans, C.B.; Go, A.T.; Visser, A.; Mulders, M.A.; Westerman, B.A.; Blankenstein, M.A.; van Vugt, J.M. Detection of chromosome 21-encoded mRNA of placental origin in maternal plasma. Clin. Chem. 2003, 49, 14451449.

23. Cicero, S.; Bindra, R.; Rembouskos, G.; Spencer, K.; Nicolaides, K.H. Integrated ultrasound and biochemical screening for trisomy 21 using fetal nuchal translucency, absent fetal nasal bone, free beta-hCG and PAPP-A at 11 to 14 weeks. Prenat. Diagn. 2003, 23, 306- 310.

Getting Started With Dumbbells

Getting Started With Dumbbells

The use of dumbbells gives you a much more comprehensive strengthening effect because the workout engages your stabilizer muscles, in addition to the muscle you may be pin-pointing. Without all of the belts and artificial stabilizers of a machine, you also engage your core muscles, which are your body's natural stabilizers.

Get My Free Ebook


Post a comment